TNIK-IN-3
Product Specifications
UNSPSC Description
TNIK-IN-3 is a potent, selective and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK), with an IC50 of 0.026 μM. TNIK-IN-3 could also inhibit Flt4 (IC50=0.030 μM), Flt1 (IC50=0.191 μM) and DRAK1 (IC50=0.411 μM). TNIK-IN-3 can be used for the research of colorectal cancer[1].
Target Antigen
DAPK
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tnik-in-3.html
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
O=C1C2=CC=C(C=C2OCCN1CC3=CC=C(C=C3)F)C4=CC5=C(NC=C5)N=C4
Molecular Weight
387.41
References & Citations
[1]Li Y, et, al. Discovery of 3,4-Dihydrobenzo[ f][1,4]oxazepin-5(2 H)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer Effects. J Med Chem. 2022 Jan 5.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145293/TNIK-IN-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145293/TNIK-IN-3-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2754265-25-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1200776-01 0.02 mg (E-Coli)
Recombinant Cicer arietinum Lactoylglutathione lyase
Ask
View Details 
MBS1200776-05 0.02 mg (Baculovirus)
Recombinant Cicer arietinum Lactoylglutathione lyase
Ask
View Details